Branding/Logomark minus Citation Combined Shape Icon/Bookmark-empty Icon/Copy Icon/Collection Icon/Close Copy 7 no author result Created with Sketch. Icon/Back Created with Sketch.
Loading Scinapse...
Fernando Flexa Ribeiro Filho
Federal University of São Paulo
12Publications
8H-index
340Citations
Publications 12
Newest
Published on Jan 1, 2015in Diabetology & Metabolic Syndrome 2.41
Bianca de Almeida Pititto (Federal University of São Paulo), Fernando Flexa Ribeiro Filho8
Estimated H-index: 8
(Federal University of São Paulo)
+ 3 AuthorsSandra Roberta Gouvea Ferreira28
Estimated H-index: 28
(Federal University of São Paulo)
Materials and methods A sample of 998 individuals from the ELSA-Brazil (35-54 yrs.) without cardiovascular disease or diabetes was stratified according to E-selectin tertiles. Traditional risk factors, inflammatory markers and categories of coronary artery calcium (CAC) score were evaluated across the tertiles by ANOVA or chi-squared test. In linear regression models, associations of E-selectin levels with insulin resistance index, adjusted for age, sex and adiposity were tested.
Source Cite
Published on Jun 14, 2012in Obesity 4.04
Sonia Maria Togeiro15
Estimated H-index: 15
(Federal University of São Paulo),
Glaucia Carneiro10
Estimated H-index: 10
(Federal University of São Paulo)
+ 5 AuthorsSergio Tufik61
Estimated H-index: 61
(Federal University of São Paulo)
Objective: Epidemiologic studies that control for potential confounders are needed to assess the independent associations of obstructive sleep apnea (OSA) with metabolic abnormalities. The aim of our study was to evaluate the associations of OSA with metabolic abnormalities among the adult population of Sao Paulo, Brazil. Design and Methods: Questionnaires were applied face-to-face, full night polysomnography (PSG) was performed, and blood samples were collected in a population-based survey in S...
47 Citations Source Cite
Maria Teresa Zanella20
Estimated H-index: 20
(Federal University of São Paulo),
Fernando Flexa Ribeiro Filho8
Estimated H-index: 8
(Federal University of São Paulo)
Central obesity have an important impact on the development of risk factors for coronary heart disease, including dislipidemia, glucose intolerance, insulin resistance and hypertension. These factors contribute to building cardiovascular (CV) disease as a major cause of death. The approach to obesity therapy should be designed to reduce CV risk and mortality. Diet and lifestyle changes remain the cornerstones of therapy for obesity, but the resultant weight loss is often small and long-term succ...
17 Citations Source Cite
Glaucia Carneiro10
Estimated H-index: 10
(Federal University of São Paulo),
Fernando Flexa Ribeiro Filho8
Estimated H-index: 8
(Federal University of São Paulo)
+ 2 AuthorsMaria Teresa Zanella20
Estimated H-index: 20
(Federal University of São Paulo)
Previous studies have shown Obstructive Sleep Apnea (OSA) as a risk factor for development of cardiovascular and cerebrovascular disease. However, controversies remain as to whether these changes are consequences of the associated obesity or OSA itself results in endocrine and metabolic changes, including impairment of insulin sensitivity, growth hormone, secretion inflammatory cytokines alterations, activation of peripheral sympathetic activity, and hipothalamic-pituitary-adrenal (HPA) axis, th...
11 Citations Source Cite
Glaucia Carneiro10
Estimated H-index: 10
,
Fernando Flexa Ribeiro Filho8
Estimated H-index: 8
+ 2 AuthorsMaria Teresa Zanella20
Estimated H-index: 20
Fernando Flexa Ribeiro Filho8
Estimated H-index: 8
(Federal University of São Paulo),
Lydia Sebba Souza Mariosa2
Estimated H-index: 2
(Federal University of São Paulo)
+ 1 AuthorsMaria Teresa Zanella20
Estimated H-index: 20
(Federal University of São Paulo)
Metabolic syndrome (MS) is seen nowadays as a worldwide epidemic event associated with high cardiovascular morbi-mortality and high socioeconomic cost. The ponderal gain is an independent predictor for the development of MS, although not all obese individuals present it. On the other hand, some populations with low obesity prevalence present high prevalence of MS and cardiovascular mortality. The distribution of corporal fat is relevant and visceral fat (VF), specifically, seems to be the link b...
108 Citations Source Cite
Fernando Flexa Ribeiro Filho8
Estimated H-index: 8
,
Lydia Sebba Souza Mariosa2
Estimated H-index: 2
+ 1 AuthorsMaria Teresa Zanella20
Estimated H-index: 20
ABSTRACT Visceral Fat and Metabolic Syndrome: More Than a Simple Association.Metabolic syndrome (MS) is seen nowadays as a worldwide epidemicevent associated with high cardiovascular morbi-mortality and highsocioeconomic cost. The ponderal gain is an independent predictor forthe development of MS, although not all obese individuals present it. Onthe other hand, some populations with low obesity prevalence presenthigh prevalence of MS and cardiovascular mortality. The distribution ofcorporal fat ...
Published on Sep 1, 2003in Revista Da Associacao Medica Brasileira 0.74
Glaucia Carneiro10
Estimated H-index: 10
,
Alessandra Nunes Faria10
Estimated H-index: 10
+ 4 AuthorsMaria Teresa Zanella20
Estimated H-index: 20
INTRODUCTION: Obese people are at higher cardiovascular risk than people with normal body weight. The objective of this study was to establish the relationship between obesity, body fat distribution and cardiovascular risk factors. METHODS: Body mass index (BMI), waist-hip ratio (WHR) systolic (SBP) and diastolic blood pressure (DBP), plasma cholesterol, triglycerides and glucose levels were determined in a population of 499 overweight and obese patients (432F/67M; age 39±12.9y). RESULTS: High p...
121 Citations Source Cite
Published on Feb 1, 2002in Arquivos Brasileiros De Cardiologia 1.32
Alessandra Nunes Faria10
Estimated H-index: 10
,
Fernando Flexa Ribeiro Filho8
Estimated H-index: 8
+ 3 AuthorsMaria Teresa Zanella20
Estimated H-index: 20
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pressure during 24 hours (ambulatory blood pressure monitoring), on left ventricular mass, and on antihypertensive therapy in 86 obese and hypertensive patients for 6 months. METHODS: The patients underwent echocardiography, ambulatory blood pressure monitoring, and measurement of the levels of hepatic enzymes prior to and after treatment with sibutramine or placebo. RESULTS: The group using sibutra...
12 Citations
Published on Feb 1, 2002in Arquivos Brasileiros De Cardiologia 1.32
Alessandra Nunes Faria10
Estimated H-index: 10
(Federal University of São Paulo),
Fernando Flexa Ribeiro Filho8
Estimated H-index: 8
(Federal University of São Paulo)
+ 3 AuthorsMaria Teresa Zanella20
Estimated H-index: 20
(Federal University of São Paulo)
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pressure during 24 hours (ambulatory blood pressure monitoring), on left ventricular mass, and on antihypertensive therapy in 86 obese and hypertensive patients for 6 months. METHODS: The patients underwent echocardiography, ambulatory blood pressure monitoring, and measurement of the levels of hepatic enzymes prior to and after treatment with sibutramine or placebo. RESULTS: The group using sibutra...
15 Citations Source Cite
12